• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾男性前列腺癌死亡率:一般人群中年龄标准化趋势上升,糖尿病男性风险增加。

Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men.

机构信息

Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

Ann Med. 2011 Mar;43(2):142-50. doi: 10.3109/07853890.2010.530683. Epub 2011 Feb 1.

DOI:10.3109/07853890.2010.530683
PMID:21284526
Abstract

BACKGROUND

To evaluate the trend of prostate cancer mortality in Taiwanese general population and the association between diabetes and prostate cancer mortality.

MATERIALS AND METHODS

In the general population during 1995-2006, the trends of prostate cancer mortality were evaluated, followed by calculation of age-specific mortality rates for age 40-64, 65-74, and ≥ 75 years. A cohort of 102,651 diabetic men aged ≥ 40 years recruited in 1995-1998 was followed prospectively.

RESULTS

The trends of crude and age-standardized mortality from prostate cancer in the general population increased significantly (P < 0.0001). In the general population, 7,966 men aged ≥ 40 years died of prostate cancer, and aging was associated with increased risk. Age-specific prostate cancer mortality suggested significantly increasing trend for ages 65-74 and ≥ 75 years. A total of 321 diabetic men died of prostate cancer (crude mortality rate 41.9/100,000 person-years). Mortality rate ratios (95% confidence interval) showed higher risk of prostate cancer mortality in the diabetic patients, with magnitude increased with decreasing age: 1.55 (1.29-1.86), 2.68 (2.29-3.13), and 6.84 (5.34-8.75) for age ≥ 75, 65-74, and 40-64 years, respectively.

CONCLUSIONS

Prostate cancer mortality in the Taiwanese general population is increasing. Diabetic patients have a higher risk of prostate cancer mortality, which is more remarkable with decreasing age.

摘要

背景

评估台湾一般人群中前列腺癌死亡率的趋势,以及糖尿病与前列腺癌死亡率之间的关系。

材料与方法

在 1995-2006 年的一般人群中,评估了前列腺癌死亡率的趋势,随后计算了 40-64、65-74 和≥75 岁年龄组的特定年龄死亡率。1995-1998 年招募了 102651 名≥40 岁的糖尿病男性进行前瞻性队列研究。

结果

一般人群中前列腺癌的粗死亡率和年龄标准化死亡率呈显著上升趋势(P<0.0001)。在一般人群中,有 7966 名≥40 岁的男性死于前列腺癌,且随着年龄的增长,风险增加。特定年龄的前列腺癌死亡率表明,65-74 岁和≥75 岁的年龄组呈显著上升趋势。共有 321 名糖尿病男性死于前列腺癌(粗死亡率为 41.9/100000 人年)。死亡率比(95%置信区间)显示糖尿病患者死于前列腺癌的风险更高,且随着年龄的降低,风险增加:年龄≥75、65-74 和 40-64 岁的风险比分别为 1.55(1.29-1.86)、2.68(2.29-3.13)和 6.84(5.34-8.75)。

结论

台湾一般人群中前列腺癌死亡率呈上升趋势。糖尿病患者死于前列腺癌的风险更高,且随着年龄的降低,风险更显著。

相似文献

1
Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men.台湾男性前列腺癌死亡率:一般人群中年龄标准化趋势上升,糖尿病男性风险增加。
Ann Med. 2011 Mar;43(2):142-50. doi: 10.3109/07853890.2010.530683. Epub 2011 Feb 1.
2
Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan.糖尿病患者膀胱癌的年龄相关死亡风险:台湾全国队列的12年随访
Ann Med. 2009;41(5):371-9. doi: 10.1080/07853890902729778.
3
Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese.糖尿病与甲状腺癌死亡率:台湾 12 年前瞻性随访研究。
Eur J Clin Invest. 2013 Jun;43(6):595-601. doi: 10.1111/eci.12086. Epub 2013 Apr 1.
4
Diabetes but not insulin is associated with higher colon cancer mortality.糖尿病而非胰岛素与更高的结肠癌死亡率相关。
World J Gastroenterol. 2012 Aug 21;18(31):4182-90. doi: 10.3748/wjg.v18.i31.4182.
5
Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.胰岛素的使用并不能显著预测糖尿病患者的前列腺癌死亡率:一项长达 12 年的随访研究。
BJU Int. 2012 Sep;110(5):668-73. doi: 10.1111/j.1464-410X.2011.10924.x. Epub 2012 Feb 2.
6
Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006.1995年至2006年台湾地区乳腺癌死亡率的长期趋势及糖尿病与乳腺癌之间的关联。
Diabetologia. 2009 Feb;52(2):240-6. doi: 10.1007/s00125-008-1204-8. Epub 2008 Nov 19.
7
Higher risk of mortality from lung cancer in Taiwanese people with diabetes.台湾糖尿病患者患肺癌的死亡风险更高。
Diabetes Res Clin Pract. 2013 Dec;102(3):193-201. doi: 10.1016/j.diabres.2013.10.019. Epub 2013 Nov 2.
8
Diabetes and risk of prostate cancer: a study using the National Health Insurance.糖尿病与前列腺癌风险:基于国民健康保险的研究。
Diabetes Care. 2011 Mar;34(3):616-21. doi: 10.2337/dc10-1640. Epub 2011 Jan 27.
9
Diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan.尽管台湾地区一般人群的年龄标准化胃癌死亡率呈下降趋势,但糖尿病仍与更高的胃癌死亡率相关。
Gut. 2011 Jun;60(6):774-9. doi: 10.1136/gut.2010.226522. Epub 2010 Dec 30.
10
Diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study.糖尿病而非胰岛素会增加患肺癌风险:一项基于台湾人群的研究。
PLoS One. 2014 Jul 3;9(7):e101553. doi: 10.1371/journal.pone.0101553. eCollection 2014.

引用本文的文献

1
Metformin: A Dual-Role Player in Cancer Treatment and Prevention.二甲双胍:癌症治疗与防治中的双重角色
Int J Mol Sci. 2024 Apr 6;25(7):4083. doi: 10.3390/ijms25074083.
2
Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.罗格列酮与 2 型糖尿病患者前列腺癌风险之间无关联。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1185053. doi: 10.3389/fendo.2023.1185053. eCollection 2023.
3
Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study.
二甲双胍对精索静脉曲张、勃起功能障碍、不育症及前列腺相关疾病的影响:一项回顾性队列研究。
Front Pharmacol. 2022 Jul 22;13:799290. doi: 10.3389/fphar.2022.799290. eCollection 2022.
4
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.泛亚地区适应的 ESMO 前列腺癌诊断、治疗和随访临床实践指南。
ESMO Open. 2022 Aug;7(4):100518. doi: 10.1016/j.esmoop.2022.100518. Epub 2022 Jul 4.
5
Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study.台湾2型糖尿病男性患者中吡格列酮与前列腺癌风险:一项回顾性队列研究
World J Mens Health. 2023 Jan;41(1):119-128. doi: 10.5534/wjmh.210157. Epub 2022 Mar 2.
6
The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review.二甲双胍对男性生殖功能和前列腺的影响:最新综述
World J Mens Health. 2022 Jan;40(1):11-29. doi: 10.5534/wjmh.210001. Epub 2021 Mar 9.
7
Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study.术前前列腺健康指数和 %p2PSA 是韩国男性前列腺癌术后病理结果的显著生物标志物:一项前瞻性多机构研究。
Investig Clin Urol. 2020 Jan;61(1):42-50. doi: 10.4111/icu.2020.61.1.42. Epub 2019 Dec 17.
8
The incidence, mortality, and risk factors of prostate cancer in Asian men.亚洲男性前列腺癌的发病率、死亡率及风险因素。
Prostate Int. 2019 Mar;7(1):1-8. doi: 10.1016/j.prnil.2018.11.001. Epub 2018 Nov 22.
9
Metformin: A Bridge between Diabetes and Prostate Cancer.二甲双胍:糖尿病与前列腺癌之间的桥梁。
Front Oncol. 2017 Oct 11;7:243. doi: 10.3389/fonc.2017.00243. eCollection 2017.
10
Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.西他列汀可能会降低2型糖尿病男性患者患前列腺癌的风险。
Oncotarget. 2017 Mar 21;8(12):19057-19064. doi: 10.18632/oncotarget.12137.